Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12615001308583
ACTRN12615001308583
Recruiting
未知

In pregnant women with a singleton pregnancy at greater than 36 weeks gestation, having intrapartum monitoring, how does ST analysis (STan) intrapartum monitoring compare to conventional cardiotocography for selected neonatal and maternal outcomes

Chris Wilkinson0 sites1,176 target enrollmentNovember 30, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Chris Wilkinson
Enrollment
1176
Status
Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 30, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Chris Wilkinson

Eligibility Criteria

Inclusion Criteria

  • •At least 18 years and capable of giving consent. Pregnancy expected to labour and deliver vaginally, singleton fetus, cephalic presentation, suitable for STan monitoring.
  • •Gestation must be greater than 36 completed weeks.

Exclusion Criteria

  • •Planned caesarean section; placenta praevia; low placenta; active vaginal infection; active genital herpes; HIV positive.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
The characterisation and correlation of cardiovascular haemodynamics and endothelial function in preeclampsia
ACTRN12613001016729Cardiology Unit, Lyell McEwin Hospital, Northern Adelaide Local Health Network110
Not yet recruiting
Not Applicable
Screening healthy women with a singleton pregnancy for a short cervical lengthshort cervical lengththreatened preterm birth10010273
NL-OMON33673Academisch Medisch Centrum38,400
Not yet recruiting
Not Applicable
An observational study to observe the effect of SARS COVID 19 infection on mother and fetus.
CTRI/2020/12/030050ady Hardinge Medical College New Delhi Smt Sucheta Kriplani Hospital
Recruiting
Phase 3
In pregnant women with previous subfertility, does progesterone supplementation decrease the likelihood of miscarriage?
ACTRN12611000401954Dr Luke McLindon344
Completed
Phase 3
Evaluation of intrauterine infusion of autologous platelet rich plasma (PRP) on in vitro fertilization (IVF)female infertility.female infertility unspecified
IRCT2016090328950N2Shahid Sadoughi University of Medical Sciences, Vice chancellor for research66